Sucharu Prakash, Director of Quality Services at Texas Oncology, shared a post on LinkedIn:
“Check out my editorial/commentary in February edition of Evidence Based Oncology. ctDNA technology continues to impress and provide us with tools we could only have imagined a few years ago.
From early detection to personalized targeted therapies to MRD detection, ctDNA has changed how we practice and most importantly, has improved patient outcomes. Legislative support helps tremendously! Education and awareness of both physicians and patients continues to be an unmet need.”
Other OncoDaily articles featuring Sucharu Prakash.